Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.

@article{Garber2012ClinicalPG,
  title={Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.},
  author={Jeffrey R. Garber and Rhoda H. Cobin and Hossein Gharib and James V. Hennessey and Irwin Klein and J. Mechanick and Rachel Pessah-Pollack and P. Alonso Singer and Kenneth A. Woeber},
  journal={Thyroid : official journal of the American Thyroid Association},
  year={2012},
  volume={22 12},
  pages={
          1200-35
        }
}
  • J. Garber, R. Cobin, K. Woeber
  • Published 6 November 2012
  • Medicine, Biology
  • Thyroid : official journal of the American Thyroid Association
BACKGROUND Hypothyroidism has multiple etiologies and manifestations. [] Key Method The authors examined relevant literature and took an evidence-based medicine approach that incorporated their knowledge and experience to develop a series of specific recommendations and the rationale for these recommendations. The strength of the recommendations and the quality of evidence supporting each was rated according to the approach outlined in the American Association of Clinical Endocrinologists Protocol for…
A 2013 survey of clinical practice patterns in the management of primary hypothyroidism.
TLDR
The current survey of clinical endocrinologists catalogs current practice patterns in the management of hypothyroidism and demonstrates a nearly exclusive preference for l-T4 alone as initial therapy, the widespread use of age-specific TSH targets for replacement therapy, and a highly variable approach to both the rate and means of restoring euthyroidism for overt disease.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THYROID DYSFUNCTION CASE FINDING.
TLDR
It is recommended that thyroid dysfunction should be frequently considered as a potential etiology for many of the nonspecific complaints that physicians face daily and advocated for an aggressive case-finding approach, based on identifying those persons most likely to have thyroid disease that will benefit from its treatment.
Aggressive Case Finding: A Clinical Strategy for the Documentation of Thyroid Dysfunction
TLDR
Aggressive case finding is defined as the process of identifying persons who are most likely to have thyroid disease, experience clinical consequences of the disease, and benefit from treatment, and the data support aggressive case finding to identify all degrees of hypothyroidism.
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.
TLDR
It is concluded that levothyroxine should remain the standard of care for treating hypothyroidism and no consistently strong evidence for the superiority of alternative preparations is found.
Diagnosis and Management of Hypothyroidism in Gulf Cooperation Council (GCC) Countries
TLDR
Recommendations included in this article aim to streamline the diagnosis and clinical management of hypothyroidism in the GCC, especially in the primary care setting, with the intention of improving treatment outcomes.
Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline
TLDR
This guideline panel concluded that almost all adults with SCH would not benefit from treatment with thyroid hormones, and clinicians should monitor the progression or resolution of the thyroid dysfunction in these adults.
How selective are the new guidelines for treatment of subclinical hypothyroidism for patients with thyrotropin levels at or below 10 mIU/L?
TLDR
This study evaluated the frequency of factors that should be considered for the treatment of subclinical hypothyroidism among adult (non-pregnant) women with SCH whose TSH levels are ≤10 mIU/L and according to the new ATA and AACE guidelines, L-T4 therapy would be considered.
...
...

References

SHOWING 1-10 OF 341 REFERENCES
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
  • R. Bahn, H. Burch, M. Stan
  • Medicine, Biology
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • 2011
TLDR
Evidence-based clinical guidelines for the management of thyrotoxicosis are described that would be useful to generalist and subspeciality physicians and others providing care for patients with this condition.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE EVALUATION AND TREATMENT OF HYPERTHYROIDISM AND HYPOTHYROIDISM.
  • H. Baskin, R. Cobin, J. Tourtelot
  • Medicine, Biology
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • 2002
These clinical practice guidelines summarize the recommendations of the American Association of Clinical Endocrinologists for the diagnostic evaluation of hyperthyroidism and hypothyroidism and for
Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association.
TLDR
A set of minimum clinical guidelines for the diagnosis and treatment of hyperthyroidism and hypothyroidism were developed by consensus of a group of experienced thyroidologists, with the expectation that more effective care can be provided, and at a cost savings.
American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update.
  • J. Mechanick, P. Camacho, D. Trence
  • Medicine
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • 2010
TLDR
The updated 2010 AACE protocol emphasizes "informed judgment" and hybridizes EBM descriptors (study design type), qualifiers (study flaws), and subjective factors (such as risk, cost, and relevance) and introduces an electronic implementation component.
Clinical practice guideline: Management of thyroid dysfunction during pregnancy and postpartum: An endocrine society clinical practice guideline
TLDR
Management of thyroid diseases during pregnancy requires special considerations because pregnancy induces major changes in thyroid function, and maternal thyroid disease can have adverse effects on the pregnancy and the fetus.
American Thyroid Association guidelines for detection of thyroid dysfunction.
TLDR
The American Thyroid Association recommends that adults be screened for thyroid dysfunction by measurement of the serum thyrotropin concentration, beginning at age 35 years and every 5 years thereafter.
Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism
TLDR
A working group to produce a consensus statement for good practice with associated audit measures which could be used to ensure that purchasers of health care are obtaining an acceptable standard of care for patients with thyroid disease focused on patient management rather than presenting symptoms and signs.
Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline.
TLDR
Practice guidelines are presented for diagnosis and treatment of patients with thyroid-related medical issues just before and during pregnancy and in the postpartum interval, including evidence-based approaches to assessing the cause of the condition, treating it, and managing hypothyroidism.
Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the american thyroid association, american association of clinical endocrinologists, and the endocrine society.
TLDR
The clinical use of contemporary LT4 products continues to be associated with some adverse outcomes, and the most frequently reported adverse outcomes were associated with the approved generic substitution ofLT4 products, frequently without the prescribing physician's knowledge.
...
...